During the past decade, Osaka Saiseikai Nakatsu Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Osaka Saiseikai Nakatsu Hospital" #1 sponsor was "Pfizer" with 3 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Chugai Pharmaceutical" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osaka Saiseikai Nakatsu Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Cardiovascular Research Foundation, New York" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Maruishi Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Osaka Saiseikai Nakatsu Hospital" are "Coronary Artery Disease" (3 trials), "Artery Diseases, Peripheral" (1 trials), "Atherosclerosis" (1 trials), "Atherosclerosis Obliterans" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Osaka Saiseikai Nakatsu Hospital" in a lesser frequency.

Most popular intervention types in "Osaka Saiseikai Nakatsu Hospital" are "Drug" (14 trials), "Device" (4 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "PF-06700841" (2 trials), "Placebo" (2 trials), "Vehicle (Placebo)" (2 trials), "3 months of dual antiplatelet therapy (DAPT)" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osaka Saiseikai Nakatsu Hospital" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Osaka Saiseikai Nakatsu Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Osaka Saiseikai Nakatsu Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Osaka Saiseikai Nakatsu Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".